Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Presents Updated Safety Data from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
AVI BioPharma, 10/27/09

AVI BioPharma, Inc., a developer of RNA–based drugs, presented an update on preliminary safety data from its ongoing systemic Phase 1b/2 clinical trial of exon skipping AVI–4658 in patients with Duchenne muscular dystrophy at the 7th Annual Action Duchenne Conference in London, UK.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Linking Images to EHRs
HealthDataManagement, 11/24/09

Boston Scientific to Participate in Piper Jaffray Health Care Conference
Boston Scientific, 11/24/09

Purdue Pharma L.P. Presents Phase 3 Study of Transdermal Delivery of Buprenorphine in Moderate to Severe Pain
Purdue, 11/24/09

 See all of Conferences/Meetings

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09

Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09

 See all of Drug Trials